Compare Align Technology, Inc. (ALGN) vs Berkshire Hathaway Inc Class B (BRK.B) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
Align Technology, Inc. vs Berkshire Hathaway Inc Class B — how do they compare? Align Technology, Inc. trades at $176.35 (market cap $13.27B), while Berkshire Hathaway Inc Class B trades at $500.81. The key difference: Berkshire Hathaway Inc Class B is trading nearer its 52-week high, Align Technology, Inc. nearer its low. Which is the better fit depends on your goals.
| ALGN | BRK.B | |
|---|---|---|
Market Cap | $13.27B | — |
Sector | Health | Financials |
52-Week High | $207.19 | $513.70 |
52-Week Low | $124.88 | $459.10 |
Enterprise Value | $12.32B | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ALGN trades at $185.22, up 0.38% today, with a bullish technical signal and strong analyst consensus. The stock has consistently beaten earnings estimates in recent quarters, with Q2 2026 results expected soon. Revenue remains stable around $4.0B, supported by a 67.57% gross margin and positive cash flow trends. Recent news highlights global expansion and product innovation, including a new manufacturing facility in India.
Outlook is positive with a $220.75 consensus price target, though risks include regulatory scrutiny from the European Commission and competitive pressures. The stock's valuation at a P/E of 31.65 reflects growth expectations, but investors should monitor execution on international growth and demand stability in North America.
BRK.B trades at $502.09, down 0.91% today, with a bullish technical signal driven by moving averages. Support levels are near $494–$501, while resistance sits at $509–$517. Analyst consensus is positive, with 57% buy ratings, though key financial ratios like P/E and P/B are not provided in the data. The stock shows strong momentum with ADX indicating a robust trend.
The outlook for BRK.B is cautiously optimistic given bullish technicals and analyst support, but the absence of recent fundamental data limits valuation clarity. Risks include market volatility and reliance on broader economic conditions. Investors should await updated earnings reports for a fuller picture of intrinsic value and growth prospects.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Align Technology, Inc.
Align is the leading manufacturer of clear dental aligners globally, having pioneered the technology with the introduction of its Invisalign branded aligners in 1998. Since then, Invisalign has become a household name, having treated over 10 million patients with malocclusion (misaligned teeth) through orthodontist and dentist-guided treatment plans. The company maintains dominant market share of clear aligners, despite the introduction of direct-to-consumer competitors upon the expiration of key patents that began in 2017. Align also manufactures intraoral scanners (iTero), used for orthodontic treatment and restorative dental procedures (digital models for crowns, veneers, and implants).
Read more on ALGN →About Berkshire Hathaway Inc Class B
Berkshire Hathaway is a holding company with diverse subsidiaries, primarily in insurance through Geico and its reinsurance groups. It reinvests profits into various industries, owning Burlington Northern Santa Fe (railroad), Berkshire Hathaway Energy, and major manufacturing, service, and retail businesses like Precision Castparts and Lubrizol. The company operates in a highly decentralized manner.
Read more on BRK.B →
